{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T07:35:47Z","timestamp":1789544147016,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T00:00:00Z","timestamp":1597017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1245\/s10434-020-08900-0","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T21:03:39Z","timestamp":1597093419000},"page":"4795-4801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Oncologic Outcomes of Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer"],"prefix":"10.1245","volume":"27","author":[{"given":"Mara A.","family":"Piltin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,10]]},"reference":[{"key":"8900_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391\u20138. (discussion 398\u2013401).","journal-title":"Ann Surg."},{"key":"8900_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Andeson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary lymph node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol."},{"key":"8900_CR3","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"8900_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4103\/ijmpo.ijmpo_21_18","volume":"40","author":"M Pathak","year":"2019","unstructured":"Pathak M, Deo SVS, Nand Dwivedi S, Sreenivas V, Thakur B, Kumar Julka P, Rath GK. Role of neoadjuvant chemotherapy in breast cancer patients: systematic review and meta-analysis. Indian J Med Paediatr Oncol. 2019;40:48.","journal-title":"Indian J Med Paediatr Oncol."},{"key":"8900_CR5","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455\u201361.","journal-title":"JAMA."},{"key":"8900_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T, et al. Sentinel lymph node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.\u00a0Lancet Oncol.\u00a02013;14:609\u201318.","journal-title":"Lancet Oncol."},{"key":"8900_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","volume":"33","author":"JF Boileau","year":"2015","unstructured":"Boileau JF, Poirier B, Basik M, et al. Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC\u00a0study.\u00a0J Clin Oncol.\u00a02015;33:258\u201364.","journal-title":"J Clin Oncol."},{"key":"8900_CR8","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","volume":"8","author":"DN Krag","year":"2007","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III TRIAL.\u00a0Lancet Oncol. 2007;8:881\u20138.","journal-title":"Lancet Oncol."},{"key":"8900_CR9","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","volume":"25","author":"TT Nguyen","year":"2018","unstructured":"Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC. Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol. 2018;25:2596\u2013602.","journal-title":"Ann Surg Oncol."},{"key":"8900_CR10","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","volume":"24","author":"AS Caudle","year":"2017","unstructured":"Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons members.\u00a0Ann Surg Oncol.\u00a02017;24:2925\u201334.","journal-title":"Ann Surg Oncol."},{"key":"8900_CR11","unstructured":"Wilke LG, et al. Consensus Guidelines on the Management of the Axilla in Patients with Invasive In Situ Breast Cancer. American Society of Breast Surgeons. 2019. https:\/\/www.breastsurgeons.org\/docs\/statements\/Consensus-Guideline-on-the-Management-of-the-Axilla.pdf?v2. Accessed 24 June 2020."},{"key":"8900_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1053\/ejso.2002.1385","volume":"29","author":"MP Schijven","year":"2003","unstructured":"Schijven MP, Vingerhoets AJJM, Rutten HJT, Nieuwenhuijzen GAP, Roumen RMH, van Bussel ME, Voogd AC. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.\u00a0Eur J Surg Oncol.\u00a02003;29:341\u201350.","journal-title":"Eur J Surg Oncol."},{"key":"8900_CR13","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K","volume":"88","author":"P Schrenk","year":"2000","unstructured":"Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.\u00a0Cancer. 2000;88:608\u201314.","journal-title":"Cancer."},{"key":"8900_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.radonc.2018.07.006","volume":"131","author":"ML Gregorowitsch","year":"2019","unstructured":"Gregorowitsch,ML, Verkooijen HM, Houweling A, et al. Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients.\u00a0Radiother Oncol.\u00a02019;131:221\u20138.","journal-title":"Radiother Oncol."},{"key":"8900_CR15","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1200\/JCO.2011.39.2779","volume":"30","author":"LJ Esserman","year":"2012","unstructured":"Esserman LJ, Berry DA, DeMichele A, et al. Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 trial\u2013CALGB 150007\/150012, ACRIN 6657. J Clin Oncol. 2012;30:3242\u20139.","journal-title":"J Clin Oncol."},{"key":"8900_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384:164\u201372.","journal-title":"Lancet."},{"key":"8900_CR17","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/SLA.0000000000002373","volume":"266","author":"J Boughey","year":"2017","unstructured":"Boughey J, Ballman KV, McCall LM, et al. Tumor biology and response to chemotherapy impact breast cancer-specific survival in node-positive breast cancer patients treated with neoadjuvant chemotherapy: long-term follow-up from ACOSOG Z1071 (Alliance).\u00a0Ann Surg. 2017;266:667\u201376.","journal-title":"Ann Surg."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08900-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T23:06:36Z","timestamp":1628550396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,10]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["8900"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08900-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,10]]},"assertion":[{"value":"19 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}